Advancing mechanistic understanding and biomarker development in amyotrophic lateral sclerosis.

Thompson, Alexander G; Oeckl, Patrick; Feneberg, Emily; Bowser, Robert; Otto, Markus; Fischer, Roman; Kessler, Benedikt; Turner, Martin R

Thompson, Alexander G; Oeckl, Patrick; Feneberg, Emily; Bowser, Robert; Otto, Markus; Fischer, Roman; Kessler, Benedikt; Turner, Martin R.

Afiliação

Thompson AG; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Oeckl P; Department of Neurology, University of Ulm, Ulm, Germany.
Feneberg E; German Center for Neurodegenerative Diseases (Dzne e.V.), Ulm, Germany.
Bowser R; Department of Neurology, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany.
Otto M; Departments of Neurology and Translational Neuroscience, Barrow Neurological Institute, Phoenix, Arizona, USA.
Fischer R; Department of Neurology, University of Ulm, Ulm, Germany.
Kessler B; Department of Neurology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
Turner MR; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Expert Rev Proteomics ; 18(11): 977-994, 2021 11.

Article em En | MEDLINE | ID: mdl-34758687

Assuntos

Esclerose Lateral Amiotrófica; Doenças Neurodegenerativas; Esclerose Lateral Amiotrófica/genética; Biomarcadores; Humanos; Proteômica

Palavras-chave

Amyotrophic lateral sclerosis; C9orf72; SOD1; TDP-43; biomarkers; cerebrospinal fluid; neurodegeneration; proteomics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Neurodegenerativas / Esclerose Lateral Amiotrófica Limite: Humans Idioma: En Revista: Expert Rev Proteomics Assunto da revista: BIOQUIMICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google